These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 2409061)

  • 1. Human T-cell responses to the RD1-encoded protein TB27.4 (Rv3878) from Mycobacterium tuberculosis.
    Agger EM; Brock I; Okkels LM; Arend SM; Aagaard CS; Weldingh KN; Andersen P
    Immunology; 2003 Dec; 110(4):507-12. PubMed ID: 14632649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms within the HLA-DR3 haplotypes. I. HLA-DR polymorphisms detected at the protein and DNA levels are reflected by T-cell recognition.
    Bontrop R; Tilanus M; Mikulski M; van Eggermond M; Termijtelen A; Giphart M
    Immunogenetics; 1986; 23(6):401-5. PubMed ID: 3013763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis distinguishes two HLA-DR3-bearing major histocompatibility complex extended haplotypes.
    Wescott MZ; Awdeh ZL; Yunis EJ; Alper CA
    Immunogenetics; 1987; 26(6):370-4. PubMed ID: 2889669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular localization and polymorphism of HLA class II restriction determinants defined by Mycobacterium leprae-reactive helper T cell clones from leprosy patients.
    Ottenhoff TH; Neuteboom S; Elferink DG; de Vries RR
    J Exp Med; 1986 Dec; 164(6):1923-39. PubMed ID: 2431092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure, function, and genetics of human class II molecules.
    Giles RC; Capra JD
    Adv Immunol; 1985; 37():1-71. PubMed ID: 2408443
    [No Abstract]   [Full Text] [Related]  

  • 6. HLA class II restriction repertoire of antigen-specific T cells. I. The main restriction determinants for antigen presentation are associated with HLA-D/DR and not with DP and DQ.
    Ottenhoff TH; Elferink DG; Hermans J; de Vries RR
    Hum Immunol; 1985 Jun; 13(2):105-16. PubMed ID: 2409060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional polymorphism of each of the two HLA-DR beta chain loci demonstrated with antigen-specific DR3- and DRw52-restricted T cell clones.
    Irlé C; Jaques D; Tiercy JM; Fuggle SV; Gorski J; Termijtelen A; Jeannet M; Mach B
    J Exp Med; 1988 Mar; 167(3):853-72. PubMed ID: 2450955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular localization of LB-Q1, a DRw52-like T-cell recognition epitope and identification at the genomic level of associated shared hybridizing fragments.
    Termijtelen A; Tilanus MG; Engelen I; Koning F; van Rood JJ
    Hum Immunol; 1987 Aug; 19(4):255-67. PubMed ID: 2445714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative and qualitative differences in HLA-DR molecules correlated with antigen-presentation capacity.
    Bontrop R; Ottenhoff T; Van Miltenburg R; Elferink D; De Vries R; Giphart M
    Eur J Immunol; 1986 Feb; 16(2):133-8. PubMed ID: 3485528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Class II determinants recognized by TNP-specific cloned human T cell lines.
    Hanke JH; Brown MF; Pollack MS; Rich RR
    Hum Immunol; 1985 Sep; 14(1):59-76. PubMed ID: 2411702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA class II restriction repertoire of antigen-specific T cells. II. Evidence for a new restriction determinant associated with DRw52 and LB-Q1.
    Ottenhoff TH; Elferink DG; Termijtelen A; Koning F; de Vries RR
    Hum Immunol; 1985 Jun; 13(2):117-23. PubMed ID: 2409061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA class-II restriction of antigen-specific T-cell activation. With special reference to the fine specificity and immunoregulation of HLA class-II restriction elements.
    Qvigstad E; Scott H; Thorsby E
    Prog Allergy; 1985; 36():73-94. PubMed ID: 3881783
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.